Skip to main content

Retinopathy of Prematurity

  • Chapter
Pediatric Ophthalmology

Abstract

• Almost seven decades after it was first described, retinopathy of prematurity (ROP) remains an important threat to pediatric vision.

• Cooperative, multicenter, prospective trials (such as CRYO-ROP and ETROP) have been useful in establishing screening and treatment guidelines for premature infants.

• An organized screening program is vital to timely detection and treatment of ROP to reduce the risk of vision loss.

• Aggressive posterior ROP is an uncommon, rapidly progressing, severe form of ROP that requires special attention.

• Documentation and communication among physicians, staff, and parents are important.

• Future advances in screening and treatment are forthcoming.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1984) An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 102:1130–1134

    Google Scholar 

  2. (1987) An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol 105:906–912

    Google Scholar 

  3. (1990) Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome: structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 108:1408–1416

    Google Scholar 

  4. (1999) The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP). J Pediatr Ophthalmol Strabismus 36:257–263

    Google Scholar 

  5. (2000) Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I. Primary outcomes. Pediatrics 105:295–310

    Google Scholar 

  6. Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol 119:1129–1133

    Google Scholar 

  7. International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991–999

    Article  Google Scholar 

  8. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus (2006) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117:572–576

    Article  Google Scholar 

  9. (2006) Erratum. Pediatrics. 118:1324

    Google Scholar 

  10. Abman S (2002) Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 87:F15

    Article  PubMed  CAS  Google Scholar 

  11. Askie LM, Henderson-Smart DJ, Irwig L, et al. (2003) Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349:959–967

    Article  PubMed  CAS  Google Scholar 

  12. Avery ME (1960) Recent increase in mortality from hyaline membrane disease. J Pediatr 57:553–559

    Article  PubMed  CAS  Google Scholar 

  13. Capone A Jr, Trese MT (2001) Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 108:2068–2070

    Article  PubMed  Google Scholar 

  14. Chan-Ling T, Tout S, Hollander H, et al. (1992) Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 33:2128–2147

    PubMed  CAS  Google Scholar 

  15. Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10:133–140

    Article  PubMed  Google Scholar 

  16. Chiang MF, Jiang L, Gelman R, et al. (2007) Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 125:875–880

    Article  PubMed  Google Scholar 

  17. Coats DK (2005) Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. Trans Am Ophthalmol Soc 103:281–312

    PubMed  Google Scholar 

  18. Coats DK, Miller AM, Hussein MA, et al. (2005) Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment. Am J Ophthalmol 140:214–222

    Article  PubMed  Google Scholar 

  19. Demorest BH (1996) Retinopathy of prematurity requires diligent follow-up care. Surv Ophthalmol 41:175–178

    Article  PubMed  CAS  Google Scholar 

  20. DiBiasie A (2006) Evidence-based review of retinopathy of prematurity prevention in VLBW and ELBW infants. Neonatal Netw 25:393–403

    PubMed  Google Scholar 

  21. Dollery CT, Bulpitt CJ, Kohner EM (1969) Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol 8:588–594

    PubMed  CAS  Google Scholar 

  22. Ells AL, Holmes JM, Astle WF, et al. (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110:2113–2117

    Article  PubMed  Google Scholar 

  23. Englert JA, Saunders RA, Purohit D, et al. (2001) The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J Perinatol 21:21–26

    Article  PubMed  CAS  Google Scholar 

  24. Finer NN, Schindler RF, Grant G, et al. (1982) Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial. Lancet 1:1087–1091

    Article  PubMed  CAS  Google Scholar 

  25. Flynn JT, Bancalari E (2000) On “supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I. Primary outcomes.” J AAPOS 4:65–66

    Article  PubMed  CAS  Google Scholar 

  26. Flynn JT, Bancalari E, Bachynski BN, et al. (1987) Retinopathy of prematurity. Diagnosis, severity, and natural history. Ophthalmology 94:620–629

    PubMed  CAS  Google Scholar 

  27. Fuchino Y, Hayashi H, Kono T, et al. (1995) Long-term follow up of visual acuity in eyes with stage 5 retinopathy of prematurity after closed vitrectomy. Am J Ophthalmol 120:308–316

    PubMed  CAS  Google Scholar 

  28. Gaynon MW (2006) Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP. Retina 26:S18–S23

    Article  PubMed  Google Scholar 

  29. Gilbert C, Rahi J, Eckstein M, et al. (1997) Retinopathy of prematurity in middle-income countries. Lancet 350:12–14

    Article  PubMed  CAS  Google Scholar 

  30. Good WV (2004) Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248; discussion 248–250

    Google Scholar 

  31. Gunn TR, Aranda JV, Little J (1978) Incidence of retrolental fibroplasia. Lancet 1:216–217

    Article  PubMed  CAS  Google Scholar 

  32. Hay WW Jr, Bell EF (2000) Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics 105:424–425

    Article  PubMed  Google Scholar 

  33. Hittner HM, Godio LB, Rudolph AJ, et al. (1981) Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 305:1365–1371

    PubMed  CAS  Google Scholar 

  34. Johnson KS, Mills MD, Karp KA, et al. (2007) Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. Am J Ophthalmol 143:723–725

    Article  PubMed  Google Scholar 

  35. Johnson L, Schaffer D, Boggs TR Jr (1974) The premature infant, vitamin E deficiency and retrolental fibroplasia. Am J Clin Nutr 27:1158–1173

    PubMed  CAS  Google Scholar 

  36. Jones JG, MacKinnon B, Good WV, et al. (2005) The early treatment for ROP (ETROP) randomized trial: study results and nursing care adaptations. Insight 30:7–13

    PubMed  Google Scholar 

  37. Katz ML, Robison WG Jr (1988) Autoxidative damage to the retina: potential role in retinopathy of prematurity. Birth Defects Orig Artic Ser 24:237–248

    PubMed  CAS  Google Scholar 

  38. Kim TI, Sohn J, Pi SY, et al. (2004) Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 18:130–134

    Article  PubMed  Google Scholar 

  39. Kivlin JD, Biglan AW, Gordon RA, et al. (1996) Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. Arch Ophthalmol 114:150–154

    PubMed  CAS  Google Scholar 

  40. Kretzer FL, Mintz-Hittner HA (1989) In: Miquel J, Quintanilha AT, Weber H (eds) Handbook of free radicals and antioxidants in biomedicine, vol 2. CRC Press, Boca Raton, pp 315–322

    Google Scholar 

  41. Lala-Gitteau E, Majzoub S, Saliba E, et al. (2007) [Epidemiology for retinopathy of prematurity: risk factors in the Tours hospital (France).] J Fr Ophtalmol 30:366–373

    Article  PubMed  CAS  Google Scholar 

  42. Liu PM, Fang PC, Huang CB, et al. (2005) Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 22:115–120

    Article  PubMed  Google Scholar 

  43. Manzoni P, Maestri A, Leonessa M, et al. (2006) Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 26:23–30

    Article  PubMed  CAS  Google Scholar 

  44. McCormick AQ (1977) Retinopathy of prematurity. Curr Probl Pediatr 7:1–28

    Article  PubMed  CAS  Google Scholar 

  45. Mills MD (2000) STOP-ROP results suggest selective use of supplemental oxygen for prethreshold ROP. Arch Ophthalmol 118:1121–1122

    PubMed  CAS  Google Scholar 

  46. Mintz-Hittner HA, Kretzer FL (1990) The rationale for cryotherapy with a prophylactic scleral buckle for zone I threshold retinopathy of prematurity. Doc Ophthalmol 74:263–268

    Article  PubMed  CAS  Google Scholar 

  47. Mittal M, Dhanireddy R, Higgins RD (1998) Candida sepsis and association with retinopathy of prematurity. Pediatrics 101:654–657

    Article  PubMed  CAS  Google Scholar 

  48. Modanlou HD, Gharraee Z, Hasan J, et al. (2006) Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest Ophthalmol Vis Sci 47:738–744

    Article  PubMed  Google Scholar 

  49. Msall ME, Phelps DL, Hardy RJ, et al. (2004) Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study. Pediatrics 113:790–799

    Article  PubMed  Google Scholar 

  50. Noyola DE, Bohra L, Paysse EA, et al. (2002) Association of candidemia and retinopathy of prematurity in very low birth weight infants. Ophthalmology 109:80–84

    Article  PubMed  Google Scholar 

  51. O’Neil JW, Hutchinson AK, Saunders RA, et al. (1998) Acquired cataracts after argon laser photocoagulation for retinopathy of prematurity. J AAPOS 2:48–51

    Article  PubMed  CAS  Google Scholar 

  52. Ozkan H, Duman N, Kumral A, et al. (2006) Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity. Physiol Res 55:267–275

    PubMed  CAS  Google Scholar 

  53. Palmer EA (1990) Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP). Doc Ophthalmol 74:245–251

    Article  PubMed  CAS  Google Scholar 

  54. Palmer EA, Flynn JT, Hardy RJ, et al. (1991) Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 98:1628–1640

    PubMed  CAS  Google Scholar 

  55. Paysse EA, Coats DK, Hussein MA, et al. (2006) Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children. Ophthalmology 113:169–176

    Article  PubMed  Google Scholar 

  56. Paysse EA, Hussein MA, Miller AM, et al. (2007) Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity. J AAPOS 11:388–392

    Article  PubMed  Google Scholar 

  57. Paysse EA, Miller A, Brady McCreery KM, et al. (2002) Acquired cataracts after diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 109:1662–1665

    Article  PubMed  Google Scholar 

  58. Prenner JL, Capone A Jr, Trese MT (2004) Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111:2271–2273

    Article  PubMed  Google Scholar 

  59. Repka MX, Palmer EA, Tung B (2000) Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 118:645–649

    PubMed  CAS  Google Scholar 

  60. Reynolds JD, Dobson V, Quinn GE, et al. (2002) Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 120:1470–1476

    PubMed  Google Scholar 

  61. Reynolds JD, Hardy RJ, Kennedy KA, et al. (1998) Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 338:1572–1576

    Article  PubMed  CAS  Google Scholar 

  62. Rota R, Riccioni T, Zaccarini M, et al. (2004) Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 6:992–1002

    Article  PubMed  CAS  Google Scholar 

  63. Rudanko SL, Fellman V, Laatikainen L (2003) Visual impairment in children born prematurely from 1972 through 1989. Ophthalmology 110:1639–1645

    Article  PubMed  Google Scholar 

  64. Shah VA, Yeo CL, Ling YL, et al. (2005) Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 34:169–178

    PubMed  CAS  Google Scholar 

  65. Silverman WA (1980) In: Retrolental Fibroplasia: A Modern Parable. Grune & Stratton, New York

    Google Scholar 

  66. Steinkuller PG, Du L, Gilbert C, et al. (1999) Childhood blindness. J AAPOS 3:26–32

    Article  PubMed  CAS  Google Scholar 

  67. Tasman W (2001) Ten-year follow-up from the CRYO-ROP study. Arch Ophthalmol 119:1200–1201

    PubMed  CAS  Google Scholar 

  68. Terry TL (1942) Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely. II. Report of cases: clinical aspects. Trans Am Ophthalmol Soc 40:262–284

    PubMed  CAS  Google Scholar 

  69. Valcamonico A, Accorsi P, Sanzeni C, et al. (2007) Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors. J Matern Fetal Neonatal Med 20:465–471

    Article  PubMed  CAS  Google Scholar 

  70. VanderVeen DK, Coats DK, Dobson V, et al. (2006) Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol 124:766–773

    Article  PubMed  Google Scholar 

  71. Villegas-Becerril E, Gonzalez-Fernandez R, Perula-Torres L, et al. (2006) [IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)]. Arch Soc Esp Oftalmol 81:641–646

    PubMed  CAS  Google Scholar 

  72. Villegas Becerril E, Fernandez Molina F, Gonzalez R, et al. (2005) [Serum IGF-I levels in retinopathy of prematurity. New indications for ROP screening]. Arch Soc Esp Oftalmol 80:233–238

    Article  PubMed  CAS  Google Scholar 

  73. Villegas Becerril E, Gonzalez Fernandez R, Fernandez Molina F, et al. (2005) Growth factor levels and ROP. Ophthalmology 112:2238

    Article  PubMed  Google Scholar 

  74. Wallace DK, Veness-Meehan KA, Miller WC (2007) Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J AAPOS 11:170–174

    Article  PubMed  Google Scholar 

  75. Wright KW, Sami D, Thompson L, et al. (2006) A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 104:78–84

    PubMed  Google Scholar 

  76. Wu C, Petersen RA, VanderVeen DK (2006) RetCam imaging for retinopathy of prematurity screening. J AAPOS 10:107–111

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Coats, D., Reddy, A. (2009). Retinopathy of Prematurity. In: Wilson, M., Trivedi, R., Saunders, R. (eds) Pediatric Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68632-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68632-3_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-68630-9

  • Online ISBN: 978-3-540-68632-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics